Credit Suisse Ag Illumina, Inc. Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

A detailed history of Credit Suisse Ag transactions in Illumina, Inc. stock. As of the latest transaction made, Credit Suisse Ag holds 639,413 shares of ILMN stock, worth $56.3 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

639,413

Previous 614,295 4.09%

Holding current value

$56.3 Million

Previous $85.5 Million 2.65%

% of portfolio

0.09%

Previous 0.08%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$127.73 - $147.2 $3.21 Million - $3.7 Million	25,118 Added 4.09%	639,413 $87.8 Million
Q4 2023 Feb 08, 2024	BUY	$92.79 - $142.53 $4.44 Million - $6.81 Million	47,808 Added 8.44%	614,295 $85.5 Million
Q3 2023 Nov 13, 2023	BUY	$128.91 - $192.44 $4.71 Million - $7.03 Million	36,550 Added 6.9%	566,487 $77.8 Million
Q2 2023 Aug 11, 2023	SELL	$183.43 - $232.67 $17.2 Million - $21.8 Million	-93,540 Reduced 15.0%	529,937 $99.4 Million
Q1 2023 May 10, 2023	BUY	$193.75 - $232.55 $10.8 Million - $13 Million	55,989 Added 9.87%	623,477 $145 Million
Q4 2022 Feb 13, 2023	BUY	$187.24 - $242.74 $5.56 Million - $7.2 Million	29,677 Added 5.52%	567,488 $115 Million
Q3 2022 Nov 10, 2022	SELL	$177.23 - $227.44 $668,157 - $857,448	-3,770 Reduced 0.7%	537,811 $103 Million
Q2 2022 Aug 12, 2022	SELL	$181.58 - $368.0 $20.5 Million - $41.5 Million	-112,722 Reduced 17.23%	541,581 $99.8 Million
Q1 2022 May 16, 2022	SELL	$303.87 - $423.8 $16.2 Million - $22.6 Million	-53,443 Reduced 7.55%	654,303 $229 Million
Q4 2021 Feb 14, 2022	SELL	$347.28 - $421.83 $8.84 Million - $10.7 Million	-25,446 Reduced 3.47%	707,746 $269 Million
Q3 2021 Nov 12, 2021	SELL	$405.61 - $524.84 $3.4 Million - $4.4 Million	-8,391 Reduced 1.13%	733,192 $297 Million
Q2 2021 Aug 16, 2021	BUY	$372.84 - $481.5 $15.4 Million - $19.9 Million	41,274 Added 5.89%	741,583 $351 Million
Q1 2021 May 14, 2021	SELL	$361.28 - $504.76 $79.3 Million - $111 Million	-219,501 Reduced 23.86%	700,309 $269 Million
Q4 2020 Feb 12, 2021	BUY	$292.7 - $370.96 $8.28 Million - $10.5 Million	28,279 Added 3.17%	919,810 $340 Million
Q3 2020 Nov 13, 2020	BUY	$268.51 - $400.74 $29.8 Million - $44.4 Million	110,826 Added 14.2%	891,531 $276 Million
Q2 2020 Aug 12, 2020	SELL	$256.46 - $373.01 $10.8 Million - $15.8 Million	-42,295 Reduced 5.14%	780,705 $289 Million
Q1 2020 May 13, 2020	BUY	$209.2 - $335.53 $18.9 Million - $30.4 Million	90,560 Added 12.36%	823,000 $225 Million
Q4 2019 Feb 12, 2020	BUY	$288.29 - $335.49 $16.1 Million - $18.8 Million	56,006 Added 8.28%	732,440 $243 Million
Q3 2019 Nov 12, 2019	BUY	$266.84 - $378.23 $7.93 Million - $11.2 Million	29,730 Added 4.6%	676,434 $206 Million
Q2 2019 Aug 14, 2019	SELL	$300.59 - $368.15 $9 Million - $11 Million	-29,955 Reduced 4.43%	646,704 $238 Million
Q1 2019 May 14, 2019	BUY	$272.57 - $321.18 $26.5 Million - $31.2 Million	97,215 Added 16.78%	676,659 $210 Million
Q4 2018 Feb 13, 2019	BUY	$272.46 - $366.54 $197,533 - $265,741	725 Added 0.13%	579,444 $174 Million
Q3 2018 Nov 13, 2018	BUY	$279.04 - $367.06 $4.64 Million - $6.11 Million	16,642 Added 2.96%	578,719 $212 Million
Q2 2018 Aug 14, 2018	SELL	$228.17 - $292.07 $43.6 Million - $55.8 Million	-190,882 Reduced 25.35%	562,077 $157 Million
Q1 2018 May 15, 2018	BUY	$209.54 - $253.91 $28.2 Million - $34.2 Million	134,513 Added 21.75%	752,959 $178 Million
Q4 2017 Feb 14, 2018	BUY	$202.23 - $230.03 $15.4 Million - $17.5 Million	75,948 Added 14.0%	618,446 $135 Million
Q3 2017 Nov 14, 2017	SELL	$172.3 - $213.93 $182,982 - $227,193	-1,062 Reduced 0.2%	542,498 $108 Million
Q2 2017 Aug 14, 2017	BUY	N/A	543,560	543,560 $94.3 Million

Others Institutions Holding ILMN

# of Institutions

970

Shares Held

151M

Call Options Held

2.37M

Put Options Held

1.41M

View Full List

About ILLUMINA, INC.

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $13.8B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

More about ILMN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account